These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 2508791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U.
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [Abstract] [Full Text] [Related]

  • 4. IIB von Willebrand's disease: pathogenetic and therapeutic studies.
    Kyrle PA, Niessner H, Dent J, Panzer S, Brenner B, Zimmerman TS, Lechner K.
    Br J Haematol; 1988 May; 69(1):55-9. PubMed ID: 3132965
    [Abstract] [Full Text] [Related]

  • 5. Hemostatic effect of normal platelet transfusion in severe von Willebrand disease patients.
    Castillo R, Monteagudo J, Escolar G, Ordinas A, Magallón M, Martín Villar J.
    Blood; 1991 May 01; 77(9):1901-5. PubMed ID: 1902120
    [Abstract] [Full Text] [Related]

  • 6. Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.
    Ching YN, Meyers KM, Brassard JA, Wardrop KJ.
    Am J Vet Res; 1994 Jan 01; 55(1):102-10. PubMed ID: 8141483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factor VIII:C increases after desmopressin in a subgroup of patients with autosomal recessive severe von Willebrand disease.
    Castaman G, Lattuada A, Mannucci PM, Rodeghiero F.
    Br J Haematol; 1995 Jan 01; 89(1):147-51. PubMed ID: 7833254
    [Abstract] [Full Text] [Related]

  • 10. Hemostasis in patients with severe von Willebrand disease improves after normal platelet transfusion and normalizes with further correction of the plasma defect.
    Castillo R, Escolar G, Monteagudo J, Aznar-Salatti J, Reverter JC, Ordinas A.
    Transfusion; 1997 Aug 01; 37(8):785-90. PubMed ID: 9280321
    [Abstract] [Full Text] [Related]

  • 11. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ.
    Thromb Haemost; 2008 Sep 01; 100(3):462-8. PubMed ID: 18766263
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies.
    Favaloro EJ, Kershaw G, Bukuya M, Hertzberg M, Koutts J.
    Haemophilia; 2001 Mar 01; 7(2):180-9. PubMed ID: 11260278
    [Abstract] [Full Text] [Related]

  • 14. Studies on the prolonged bleeding time in von Willebrand's disease.
    Mannucci PM, Pareti FI, Holmberg L, Nilsson IM, Ruggeri ZM.
    J Lab Clin Med; 1976 Oct 01; 88(4):662-71. PubMed ID: 787458
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R.
    Haemophilia; 2008 May 01; 14(3):524-30. PubMed ID: 18284449
    [Abstract] [Full Text] [Related]

  • 16. Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.
    Casonato A, Sartori MT, Pontara E, Zucchetto A, Dannhäuser D, Patrassi G, Girolami A.
    Blood Coagul Fibrinolysis; 1992 Apr 01; 3(2):149-53. PubMed ID: 1606286
    [Abstract] [Full Text] [Related]

  • 17. [Diagnosis and management of von Willebrand disease].
    Higasa S, Tokugawa T, Sawada A.
    Rinsho Ketsueki; 2018 Apr 01; 59(10):2222-2232. PubMed ID: 30305529
    [Abstract] [Full Text] [Related]

  • 18. Desmopressin (DDAVP) use in patients with von Willebrand disease: A single-centre retrospective review of test response and clinical outcomes.
    Chandrakumaran P, Hews-Girard J, Poon MC.
    Haemophilia; 2023 Jul 01; 29(4):1095-1103. PubMed ID: 37257847
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.